{
    "name": "dorzolamide",
    "comment": "Rx",
    "other_names": [
        "Trusopt"
    ],
    "classes": [
        "Antiglaucoma",
        "Carbonic Anhydrase Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/trusopt-dorzolamide-343604",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies in pregnant women"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Drug caused fetal vertebral malformations when administered orally to rabbits at 2.5 mg/kg/day (37 times the clinical exposure)",
                    "Drug administered during period of organogenesis was not teratogenic in rabbits dosed up to 1 mg/kg/day (15 times the clinical exposure)",
                    "Drug administered orally to rats during late gestation and lactation caused growth delays in offspring at 7.5 mg/kg/day (52 times the clinical exposure); growth was not delayed at 1 mg/kg/day (8.0 times the clinical exposure)"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on presence of drug in human milk, effects on breastfed infant, or on milk production; developmental and health benefits of breastfeeding should be considered along with mother's clinical need for therapy and any potential adverse effects on breastfed child from drug; drug is present in milk of lactating rats"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Severe renal impairment (CrCl<30 mL/min)"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Bacterial contamination can occur with multiple dose ophthalmic solutions and cause bacterial keratitis",
                "Remove contact lenses, since the solution contains benzalkonium chloride which may be absorbed by some lenses",
                "Absorbed systemically, potential risk of adverse effects similar to those for systemic sulfonamides (eg, Stevens-Johnson syndrome, blood dyscrasias, fulminant hepatic necrosis, and toxic necrolysis) may occur with ophthalmic use; sensitization may recur when sulfonamide is readministered irrespective of route of administration; if signs of serious reactions or hypersensitivity occur, discontinue use",
                "Conjunctivitis and lid reactions reported with chronic administration (may resolve with discontinuation of drug therapy",
                "Carbonic anhydrase activity observed in both cytoplasm and around the plasma membranes of the corneal endothelium; there is an increased potential for developing corneal edema in patients with low endothelial cell counts; use caution when prescribing to this group of patients",
                "Use concomitantly with oral carbonic anhydrase inhibitors not recommended",
                "Management of patients with acute angle-closure glaucoma requires therapeutic interventions in addition to ocular hypotensive agents"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Ocular burning",
            "percent": "33"
        },
        {
            "name": "stinging",
            "percent": "25"
        },
        {
            "name": "discomfort",
            "percent": "10-15"
        },
        {
            "name": "Bitter taste",
            "percent": "10"
        },
        {
            "name": "Superficial punctate keratitis",
            "percent": null
        },
        {
            "name": "Ocular allergic reactions",
            "percent": null
        },
        {
            "name": "Blurred vision",
            "percent": null
        },
        {
            "name": "Ocular dryness",
            "percent": null
        },
        {
            "name": "Photophobia",
            "percent": null
        },
        {
            "name": "Ocular redness",
            "percent": null
        },
        {
            "name": "Tearing",
            "percent": null
        },
        {
            "name": "Stevens",
            "percent": null
        },
        {
            "name": "Johnson syndrome",
            "percent": null
        },
        {
            "name": "Toxic epidermal necrolysis",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "Bronchospasm",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Epistaxis",
            "percent": null
        }
    ]
}